본문 바로가기
bar_progress

Text Size

Close

US FDA Phase 2 Clinical Trial Approval!! 'Stock Soars' Rare Drug Designation!! Rising Rapidly.

Those who applied for < YMT(251370) > hit the upper limit on Wednesday in just one day! Achieved 30% profit!

Congratulations to everyone who applied for the free trial. ^^


※ For those who missed it, no worries. We are going out big once again.

※ Finally starting. YMT(251370) follow-up stock hits the upper limit on Friday. ※

▶▶ Starting huge with the ‘upper limit’ on January 22! US FDA Phase 2 clinical trial approval!! Designated as an orphan drug!! Soaring instantly related to ‘treatment’ ▶ Apply for free trial ◀

This company announced at the JP Morgan Conference that the US FDA has approved Phase 2 clinical trials for its innovative orphan disease treatment drug! It shows superior solubility and stability compared to existing glucagon drugs, and is expected to demonstrate revolutionary results in this Phase 2 clinical trial!!

▶▶ Heading straight ‘up’ this Friday. Moving fast!! Proven safety and efficacy!! Strong surge with Phase 2 approval! The leading stock in ‘treatment’! [Apply now for stocks related to ‘ㅇㅇㅇㅇ’]


"I applied and bought small amounts every day for 3 days, and was amazed to see upper limit profits every day. I was really surprised. How this is possible is truly amazing. It’s been about 3 months since I paid the membership fee and received VIP service, and already 30 million KRW has accumulated in my account. Thank you so much again. Ah! I am actively recommending it to my acquaintances as well."

(VIP office worker Yoo Jin Lee, 41 years old)


Now think of this as the last chance. If you miss this opportunity, you have to give up.

Exactly on “January 22” it will explode! Don’t miss out and regret it, buy at least 1 million KRW worth!



▶▶ “January 22 Upper Limit” offered only until today and then closed. [Receive stocks related to ‘ㅇㅇㅇㅇ’!] ▶ Receive stocks ◀


[AI recent upper limit hits]

*21.01.18 Shinsegae Construction(034300) upper limit hit!

*21.01.15 Korea Pharma(032300) upper limit hit!

*21.01.13 Dongbang(004140) 3 consecutive upper limit hits!

*21.01.12 Dongbang(004140) 2 consecutive upper limit hits!

*21.01.11 Dongbang(004140) upper limit hit!

*21.01.08 Lanix(317120) upper limit hit!

*21.01.06 Samsung Pharmaceutical(001360) upper limit hit!

*21.01.04 Green Cross LabCell(144510) upper limit hit!

*20.12.30 Hana Technology(299030) upper limit hit!

*20.12.28 Geumbi(008870) upper limit hit!

*20.12.24 Alchera(347860) upper limit hit!

*20.12.23 LG Electronics(066570) upper limit hit!

*20.12.21 Daewoong Pharmaceutical(069620) upper limit hit!

*20.12.18 Humasis(205470) upper limit hit!

*20.12.16 Ringnet(042500) upper limit hit!


▶▶ Only 15 spots available. “Friday Upper Limit”! ▶ Get it now ◀


※ First-come, first-served 10 spots closed! Both early and late rounds are over. The hero of the final injury time winning goal ※


[Today's stocks of interest]

#Orient Bio #Samsung Pharmaceutical #Midas AI #Zenen Bio #Philux


※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top